2006
DOI: 10.1016/j.nmd.2006.07.023
|View full text |Cite
|
Sign up to set email alerts
|

Muscle cell and motor protein function in patients with a IIa myosin missense mutation (Glu-706 to Lys)

Abstract: The pathogenic events leading to the progressive muscle weakness in patients with a E706K mutation in the head of the myosin heavy chain (MyHC) IIa were analysed at the muscle cell and motor protein levels. Contractile properties were measured in single muscle fiber segments using the skinned fiber preparation and a single muscle fiber in vitro motility assay. A dramatic impairment in the function of the IIa MyHC isoform was observed at the motor protein level. At the single muscle fiber level, on the other ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
9
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 39 publications
5
9
0
Order By: Relevance
“…In accordance with previous studies, the motility speed of all the species demonstrated a high temperature dependence (Rossi et al. 2005, Li et al. 2006), i.e.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In accordance with previous studies, the motility speed of all the species demonstrated a high temperature dependence (Rossi et al. 2005, Li et al. 2006), i.e.…”
Section: Discussionsupporting
confidence: 92%
“…However, the relative and frequently absolute differences in motility speed between different MyHC isoforms decreased with increasing temperature in accordance with previous studies in rat, rabbit and humans (Rossi et al. 2005, Li et al. 2006).…”
Section: Discussionsupporting
confidence: 92%
“…The results from this study confirmed and extended our previous studies: (i) The significant difference between different myosin isoforms in speed and force-generating capacity was confirmed at the motor protein level (Hook et al ., 1999 ; Hook & Larsson, 2000 ; Hook et al ., 2001 ; Li et al ., 2006 ; Li & Larsson, 2010 ). (ii) An aging-related slowing of motility speed was observed in both type I and IIa MyHC assays, but the force-generating capacity was unaffected by age, irrespective of MyHC isoform.…”
Section: Discussionmentioning
confidence: 99%
“…To keep sarcomeres in a relaxed state, embryos were incubated in relaxation buffer (20 mM imadazole, 5 mM EGTA, 7 mM MgCl2, 5 mM creatine phosphate, 10 mM ATP, 100 mM KCl) for 1.5 h before flxation (Brixius et al, 2000; Li et al, 2006). The following antibodies were used at the indicated dilutions: anti-sarcomeric α-actinin (clone EA53, Sigma) at 1:1000, F59 (Developmental Studies Hybridoma Bank, DSHB) at 1:10, MEF2 (C-21, Santa Cruz Biotechnology) at 1:50, anti-myomesin (DSHB) at 1:100, anti-tropomyosin (CH1, Sigma) at 1:100, anti-troponin T (Sigma) at 1:200, anti-cardiac and skeletal troponin I (ABR-Affinity BioReagents) at 1:200, and Zn5 (ZIRC) at 1:500.…”
Section: Methodsmentioning
confidence: 99%